Deciphering genetic disease in the genomic era: The model of GnRH deficiency

Science Translational Medicine

Volumn 2, Issue 32, 2010, Pages

  Sykiotis, Gerasimos P ^a   Pitteloud, Nelly ^a   Seminara, Stephanie B ^a   Kaiser, Ursula B ^a,b   Crowley Jr , William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN;

FERTILITY; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC SCREENING; GENETIC VARIABILITY; GONADOTROPIN DEFICIENCY; HOMOZYGOSITY; HUMAN; MONOGENIC DISORDER; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

ANIMALS; COOPERATIVE BEHAVIOR; FERTILITY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOMICS; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; INTERNATIONAL COOPERATION; MUTATION; PEDIGREE; PHENOTYPE; TRANSLATIONAL RESEARCH;

EID: 77952981747     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000288     Document Type: Review

References (58)

1. B. M. Nathan, M. R. Palmert, Regulation and disorders of pubertal timing. Endocrinol. Metab. Clin. North Am. 34, 617-641 (2005).
2. M. M. Grumbach, A window of opportunity: The diagnosis of gonadotropin deficiency in the male infant. J. Clin. Endocrinol. Metab. 90, 3122-3127 (2005).
3. So much more to know. Science 309, 78-102 (2005).
4. P. M. Conn, W. F. Crowley Jr., Gonadotropin-releasing hormone and its analogues. N. Engl. J. Med. 324, 93-103 (1991).
5. S. B. Seminara, F. J. Hayes, W. F. Crowley Jr., Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): Pathophysiological and genetic considerations. Endocr. Rev. 19, 521-539 (1998).
6. J. L. Jameson, Rites of passage through puberty: A complex genetic ensemble. Proc. Natl. Acad. Sci. U.S.A. 104, 17247-17248 (2007).
7. S. D. Bianco, U. B. Kaiser, The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat. Rev. Endocrinol. 5, 569-576 (2009).
8. N. Santoro, J. P. Butler, M. Filicori, W. F. Crowley Jr., Alterations of the hypothalamic GnRH interpulse interval sequence over the normal menstrual cycle. Am. J. Physiol. 255, E696-E701 (1988).
9. J. Waldstreicher, N. F. Santoro, J. E. Hall, M. Filicori, W. F. Crowley Jr., Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization. J. Clin. Endocrinol. Metab. 66, 165-172 (1988).
10. R. Balasubramanian, A. Dwyer, S. B. Seminara, N. Pitteloud, U. B. Kaiser, W. F. Crowley Jr., Human GnRH deficiency: A unique disease model to unravel the ontogeny of GnRH neurons. Neuroendocrinology, in press.
11. B. Franco, S. Guioli, A. Pragliola, B. Incerti, B. Bardoni, R. Tonlorenzi, R. Carrozzo, E. Maestrini, M. Pieretti, P. Taillon-Miller, C. J. Brown, H. F. Willard, C. Lawrence, M.G. Persico, G. Camerino, A. Ballabio, A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353, 529-536 (1991).
12. R. Legouis, J. P. Hardelin, J. Levilliers, J. M. Claverie, S. Compain, V. Wunderle, P. Millasseau, D. Le Paslier, D. Cohen, D. Caterina, L. Bougueleret, H. Delemarre-Van de Waal, G. Lutfalla, J. Weissenbach, C. Petit, The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67, 423-435 (1991).
13. N. de Roux, E. Genin, J. C. Carel, F. Matsuda, J. L. Chaussain, E. Milgrom, Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. U.S.A. 100, 10972-10976 (2003).
14. S. B. Seminara, S. Messager, E. E. Chatzidaki, R. R. Thresher, J. S. Acierno Jr., J. K. Shagoury, Y. Bo-Abbas, W. Kuohung, K. M. Schwinof, A. G. Hendrick, D. Zahn, J. Dixon, U. B. Kaiser, S. A. Slaugenhaupt, J. F. Gusella, S. O'Rahilly, M. B. Carlton, W. F. Crowley Jr., S. A. Aparicio, W. H. Colledge, The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 349, 1614-1627 (2003).
15. A. K. Topaloglu, F. Reimann, M. Guclu, A. S. Yalin, L. D. Kotan, K. M. Porter, A. Serin, N. O. Mungan, J. R. Cook, M. N. Ozbek, S. Imamoglu, N. S. Akalin, B. Yuksel, S. O'Rahilly, R. K. Semple, TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat. Genet. 41, 354-358 (2009).
16. E. Gianetti, C. Tusset, S. D. Noel, M. G. Au, A. A. Dwyer, V. A. Hughes, A. P. Abreu, J. Carroll, E.Trarbach, L. F. Silveira, E. M. Costa, B. B. de Mendonca, M. de Castro, A. Lofrano, J. E. Hall, E. Bolu, M. Ozata, R. Quinton, J. K. Amory, S. E. Stewart, W. Arlt, T. R. Cole, W. F. Crowley, U. B. Kaiser, A. C. Latronico, S. B. Seminara, TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J. Clin. Endocrinol. Metab. 10.1210/jc.2009-2320 (2010).
17. N. de Roux, J. Young, M. Misrahi, R. Genet, P. Chanson, G. Schaison, E. Milgrom, A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 337, 1597-1602 (1997).
18. P. Caron, S. Chauvin, S. Christin-Maitre, A. Bennet, N. Lahlou, R. Counis, P. Bouchard, M. L. Kottler, Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J. Clin. Endocrinol. Metab. 84, 990-996 (1999).
19. R. Quinton, V. M. Duke, A. Robertson, J. M. Kirk, G. Matfin, P. A. de Zoysa, C. Azcona, G. S. MacColl, H. S. Jacobs, G. S. Conway, M. Besser, R. G. Stanhope, P. M. Bouloux, Idiopathic gonadotrophin deficiency: Genetic questions addressed through phenotypic characterization. Clin. Endocrinol. 55, 163-174 (2001).
20. C. Dode, J. Levilliers, J. M. Dupont, A. De Paepe, N. Le Du, N. Soussi-Yanicostas, R. S. Coimbra, S. Delmaghani, S. Compain-Nouaille, F. Baverel, C. Pecheux, D. Le Tessier, C. Cruaud, M. Delpech, F. Speleman, S. Vermeulen, A. Amalfitano, Y. Bachelot, P. Bouchard, S. Cabrol, J. C. Carel, H. Delemarre-van de Waal, B. Goulet-Salmon, M. L. Kottler, O. Richard, F. Sanchez-Franco, R. Saura, J. Young, C. Petit, J. P. Hardelin, Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 33, 463-465 (2003). (Pubitemid 36390006)
21. N. Pitteloud, J. S. Acierno Jr., A. Meysing, A. V. Eliseenkova, J. Ma, O. A. Ibrahimi, D. L. Metzger, F.J. Hayes, A. A. Dwyer, V. A. Hughes, M.Yialamas, J. E. Hall, E.Grant, M. Mohammadi, W. F. Crowley Jr., Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U.S.A. 103, 6281-6286 (2006).
22. T. A. Manolio, Cohort studies and the genetics of complex disease. Nat. Genet. 41, 5-6 (2009).
23. D. B. Goldstein, Common genetic variation and human traits. N. Engl. J. Med. 360, 1696-1698 (2009).
24. R. A. Hegele, Plasma lipoproteins: Genetic influences and clinical implications. Nat. Rev. Genet. 10, 109-121 (2009).
25. S. P. Dickson, K. Wang, I. Krantz, H. Hakonarson, D. B. Goldstein, Rare variants create synthetic genome-wide associations. PLoS Biol. 8, e1000294 (2010).
26. K. Kajiwara, E. L. Berson, T. P. Dryja, Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264, 1604-1608 (1994).
27. J. Hoefele, M. T. Wolf, J. F. O'Toole, E. A. Otto, U. Schultheiss, G. Dêschenes, M. Attanasio, B.Utsch, C. Antignac, F. Hildebrandt, Evidence of oligogenic inheritance in nephronophthisis. J. Am. Soc Nephrol. 18, 2789-2795 (2007).
28. N. Katsanis, The oligogenic properties of Bardet-Biedl syndrome. Hum. Mol. Genet. 13, R65-R71 (2004).
29. J. L. Badano, N. Katsanis, Beyond Mendel: An evolving view of human genetic disease transmission. Nat. Rev. Genet. 3, 779-789 (2002).
30. N. Pitteloud, S. Durrani, T. Raivio, G. P. Sykiotis, Complex genetics in idiopathic hypogonadotropic hypogonadism. Front. Horm. Res. 39, 142-153 (2010).
31. L. B. Nachtigall, P. A. Boepple, F. P. Pralong, W. F. Crowley Jr., Adult-onset idiopathic hy-pogonadotropic hypogonadism-a treatable form of male infertility. N. Engl. J. Med. 336, 410-415 (1997).
32. T. Raivio, J. Falardeau, A. Dwyer, R. Quinton, F. J. Hayes, V. A. Hughes, L. W. Cole, S. H. Pearce, H. Lee, P. Boepple, W. F. Crowley Jr., N. Pitteloud, Reversal of idiopathic hypogo-nadotropic hypogonadism. N. Engl. J. Med. 357, 863-873 (2007).
33. J. Bouligand, C. Ghervan, J. A. Tello, S. Brailly-Tabard, S. Salenave, P. Chanson, M. Lombès, R. P. Millar, A. Guiochon-Mantel, J. Young, Isolated familial hypogonadotropic hypogonadism and a GNRHI mutation. N. Engl. J. Med. 360, 2742-2748 (2009).
34. Y. M. Chan, A. de Guillebon, M. Lang-Muritano, L. Plummer, F. Cerrato, S.Tsiaras, A. Gaspert, H. B. Lavoie, C. H. Wu, W. F. Crowley Jr., J. K. Amory, N. Pitteloud, S. B. Seminara, GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U.S.A. 106, 11703-11708 (2009).
35. K. Miura, J. S. Acierno Jr., S. B. Seminara, Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J. Hum. Genet. 49, 265-268 (2004).
36. K. L. Ng, J. D. Li, M. Y. Cheng, F. M. Leslie, A. G. Lee, Q. Y. Zhou, Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 308, 1923-1927 (2005).
37. S. Matsumoto, C. Yamazaki, K. H. Masumoto, M. Nagano, M. Naito, T. Soga, H. Hiyama, M. Matsumoto, J. Takasaki, M. Kamohara, A. Matsuo, H. Ishii, M. Kobori, M. Katoh, H. Matsushime, K. Furuichi, Y. Shigeyoshi, Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc. Natl. Acad. Sci. U.S.A. 103, 4140-4145 (2006).
38. J. Falardeau, W. C. Chung, A. Beenken, T. Raivio, L. Plummer, Y. Sidis, E. E. Jacobson-Dickman, A. V. Eliseenkova, J. Ma, A. Dwyer, R. Quinton, S. Na, J. E. Hall, C. Huot, N. Alois, S. H. Pearce, L. W. Cole, V. Hughes, M. Mohammadi, P. Tsai, N. Pitteloud, Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 118, 2822-2831 (2008).
39. M. T. Dattani, The candidate gene approach to the diagnosis of monogenic disorders. Horm. Res. 71 (Suppl. 2), 14-21 (2009).
40. T. T. Kung, Y. Crawley, H. Jones, B. Luo, H. Gilchrest, S. Greenfeder, J. C. Anthes, S. Lira, M. Wiekowski, D. N. Cook, J. A. Hey, R. W. Egan, R. W. Chapman, Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacol. Res. 50, 611-615 (2004).
41. E. Zanaria, F. Muscatelli, B. Bardoni, T. M. Strom, S. Guioli, W. Guo, E. Lalli, C. Moser, A. P. Walker, E. R. McCabe, T. Meitinger, A. P. Monaco, P. Sassone-Corsi, G. Camerino, An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372, 635-641 (1994).
42. F. Muscatelli, T. M. Strom, A. P. Walker, E. Zanaria, D. Récan, A. Meindl, B. Bardoni, S. Guioli, G. Zehetner, W. Rabl, H. P. Schwarz, J.-C. Kaplan, G. Camerino, T. Meitinger, A. P. Monaco, Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372, 672-676 (1994).
43. L. E. Vissers, C. M. van Ravenswaaij, R. Admiraal, J. A. Hurst, B. B. de Vries, I. M. Janssen, W. A. van der Vliet, E. H. Huys, P. J. de Jong, B. C. Hamel, E. F. Schoenmakers, H. G. Brunner, J. A. Veltman, A. G. van Kessel, Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 36, 955-957 (2004).
44. H. G. Kim, I. Kurth, F. Lan, I. Meliciani, W. Wenzel, S. H. Eom, G. B. Kang, G. Rosenberger, M. Tekin, M. Ozata, D. P. Bick, R. J. Sherins, S. L. Walker, Y. Shi, J. F. Gusella, L. C. Layman, Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 83, 511-519 (2008).
45. A. Strobel, T. Issad, L. Camoin, M. Ozata, A. D. Strosberg, A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18, 213-215 (1998).
46. K. Clément, C. Vaisse, N. Lahlou, S. Cabrol, V. Pelloux, D. Cassuto, M. Gourmelen, C. Dina, J. Chambaz, J. M. Lacorte, A. Basdevant, P. Bougnères, Y. Lebouc, P. Froguel, B. Guy-Grand, A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398-401 (1998).
47. S. O'Rahilly, H. Gray, P. J. Humphreys, A. Krook, K. S. Polonsky, A. White, S. Gibson, K. Taylor, C.Carr, Brief report: Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N. Engl. J. Med. 333, 1386-1390 (1995).
48. R. S. Jackson, J. W. Creemers, S. Ohagi, M. L. Raffin-Sanson, L. Sanders, C. T. Montague, J. C. Hutton, S. O'Rahilly, Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303-306 (1997).
49. C. Dodé, L. Teixeira, J. Levilliers, C. Fouveaut, P. Bouchard, M. L. Kottler, J. Lespinasse, A. Lienhardt-Roussie, M. Mathieu, A. Moerman, G. Morgan, A. Murat, J. E. Toublanc, S. Wolczynski, M. Delpech, C. Petit, J. Young, J. P. Hardelin, Kallmann syndrome: Mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2, e175 (2006).
50. N. Pitteloud, R. Quinton, S. Pearce, T. Raivio, J. Acierno, A. Dwyer, L. Plummer, V. Hughes, S. Seminara, Y. Z. Cheng, W. P. Li, G. Maccoll, A. V. Eliseenkova, S. K. Olsen, O. A. Ibrahimi, F. J. Hayes, P. Boepple, J. E. Hall, P. Bouloux, M. Mohammadi, W. Crowley, Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 117, 457-463 (2007).
51. M. L. Metzker, Sequencing technologies-the next generation. Nat. Rev. Genet. 11, 31-46 (2010).
52. M. Choi, U. I. Scholl, W. Ji, T. Liu, I. R. Tikhonova, P. Zumbo, A. Nayir, A. Bakkaloglu, S. Ozen, S. Sanjad, C. Nelson-Williams, A. Farhi, S. Mane, R. P. Lifton, Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl. Acad. Sci. U.S.A. 106, 19096-19101 (2009).
53. S. B. Ng, K. J. Buckingham, C. Lee, A. W. Bigham, H. K. Tabor, K. M. Dent, C. D. Huff, P. T. Shannon, E. W. Jabs, D. A. Nickerson, J. Shendure, M. J. Bamshad, Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 42, 30-35 (2010).
54. M. Shinawi, S. W. Cheung, The array CGH and its clinical applications. Drug Discov. Today 13, 760-770 (2008).
55. J. R. Gibbs, A. Singleton, Application of genome-wide single nucleotide polymorphism typing: Simple association and beyond. PLoS Genet. 2, e150 (2006).
56. D. Altshuler, M.J. Daly, E. S. Lander, Genetic mapping in human disease. Science 322, 881-888.
57. J. N. Hirschhorn, Genomewide association studies-illuminating biologic pathways. N. Engl. J. Med. 360, 1699-1701 (2009).
58. J. McClellan, M. C. King, Genetic heterogeneity in human disease. Cell 141, 210-217 (2010).